anonymous
Guest
anonymous
Guest
Seriously, why would Lilly sign a co-promote agree with Kowa promoting "the biggest drug in pharmaceutical history beating statins" ? Great Leadership? I think not. So give me a few good reasons why you think this may happen?
I think we ALL agree at this point that it is not zepbound. It was wishful thinking by all of us derived from a level of hope after coming out of the hell of Seglentis and the poor leadership decisions. At this point, given that we have not heard anything there is a high likelihood that the deal fell through for any drug and kowa has nothing in its immediate pipeline.